1. Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress–related diseases, such as atherosclerosis. (June 2019) Authors: Sahin, E; Dabagoglu Psav, S; Avan, I; Candan, M; Sahinturk, V; Koparal, AT Journal: Human & experimental toxicology Issue: Volume 38:Number 6(2019) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗